HCC Treatment Shifts Toward Immunotherapy, but Survival Gains Remain Limited: JAMA Study Shows
USA: A large real-world analysis published in JAMA Network Open offers new insights into how systemic treatment strategies for hepatocellular carcinoma (HCC) have evolved over the past decade, while also…